SG194399A1 - Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody - Google Patents

Info

Publication number

SG194399A1

SG194399A1 SG2013073952A SG2013073952A SG194399A1 SG 194399 A1 SG194399 A1 SG 194399A1 SG 2013073952 A SG2013073952 A SG 2013073952A SG 2013073952 A SG2013073952 A SG 2013073952A SG 194399 A1 SG194399 A1 SG 194399A1

Authority

SG

Singapore

Prior art keywords

seq

cdr

single chain

chain antibody

bispecific single

Prior art date

2008-10-01

Links

• Espacenet
• Global Dossier
• Discuss

• 230000027455 binding Effects 0.000 claims abstract description 339
• 241000282414 Homo sapiens Species 0.000 claims abstract description 235
• 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 135
• 241000282577 Pan troglodytes Species 0.000 claims abstract description 114
• 238000000034 method Methods 0.000 claims abstract description 100
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims abstract description 85
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims abstract description 84
• 101710120463 Prostate stem cell antigen Proteins 0.000 claims abstract description 78
• 102100036735 Prostate stem cell antigen Human genes 0.000 claims abstract description 78
• 102100038083 Endosialin Human genes 0.000 claims abstract description 77
• 101710144543 Endosialin Proteins 0.000 claims abstract description 74
• 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims abstract description 73
• 239000000427 antigen Substances 0.000 claims abstract description 67
• 108091007433 antigens Proteins 0.000 claims abstract description 67
• 102000036639 antigens Human genes 0.000 claims abstract description 67
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 59
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 43
• -1 encoded by exon 2 Proteins 0.000 claims abstract description 41
• 239000013598 vector Substances 0.000 claims abstract description 37
• 102000005962 receptors Human genes 0.000 claims abstract description 23
• 108020003175 receptors Proteins 0.000 claims abstract description 23
• 108010072257 fibroblast activation protein alpha Proteins 0.000 claims abstract description 21
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 17
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 17
• 230000008569 process Effects 0.000 claims abstract description 15
• 238000004519 manufacturing process Methods 0.000 claims abstract description 11
• 102000012545 EGF-like domains Human genes 0.000 claims abstract description 10
• 108050002150 EGF-like domains Proteins 0.000 claims abstract description 10
• 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 claims abstract description 6
• 102000008022 Proto-Oncogene Proteins c-met Human genes 0.000 claims abstract description 6
• 102100026445 A-kinase anchor protein 17A Human genes 0.000 claims abstract description 3
• 101000718019 Homo sapiens A-kinase anchor protein 17A Proteins 0.000 claims abstract description 3
• 102100027368 Histone H1.3 Human genes 0.000 claims description 244
• 101001009450 Homo sapiens Histone H1.3 Proteins 0.000 claims description 244
• 206010028980 Neoplasm Diseases 0.000 claims description 202
• 201000011510 cancer Diseases 0.000 claims description 114
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 108
• 229920001184 polypeptide Polymers 0.000 claims description 104
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 104
• 239000003814 drug Substances 0.000 claims description 83
• 229940079593 drug Drugs 0.000 claims description 68
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 50
• 230000014509 gene expression Effects 0.000 claims description 47
• 201000009030 Carcinoma Diseases 0.000 claims description 46
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 44
• 206010060862 Prostate cancer Diseases 0.000 claims description 40
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 32
• 150000001875 compounds Chemical class 0.000 claims description 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 26
• 238000011282 treatment Methods 0.000 claims description 26
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
• 201000010099 disease Diseases 0.000 claims description 25
• 239000000203 mixture Substances 0.000 claims description 25
• 210000002307 prostate Anatomy 0.000 claims description 25
• 208000023275 Autoimmune disease Diseases 0.000 claims description 22
• 210000000481 breast Anatomy 0.000 claims description 22
• 201000001441 melanoma Diseases 0.000 claims description 22
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 21
• 210000004072 lung Anatomy 0.000 claims description 21
• 206010027406 Mesothelioma Diseases 0.000 claims description 20
• 206010039491 Sarcoma Diseases 0.000 claims description 20
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 20
• 201000002528 pancreatic cancer Diseases 0.000 claims description 20
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 20
• 230000002265 prevention Effects 0.000 claims description 19
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 12
• 210000004185 liver Anatomy 0.000 claims description 12
• 206010005003 Bladder cancer Diseases 0.000 claims description 11
• 208000032612 Glial tumor Diseases 0.000 claims description 11
• 206010018338 Glioma Diseases 0.000 claims description 11
• 208000034578 Multiple myelomas Diseases 0.000 claims description 11
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 11
• 210000001072 colon Anatomy 0.000 claims description 11
• 210000003734 kidney Anatomy 0.000 claims description 11
• 210000000496 pancreas Anatomy 0.000 claims description 11
• 238000002360 preparation method Methods 0.000 claims description 11
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 11
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 claims description 10
• 102100025390 Integrin beta-2 Human genes 0.000 claims description 10
• 206010025323 Lymphomas Diseases 0.000 claims description 10
• 206010029260 Neuroblastoma Diseases 0.000 claims description 10
• 208000009277 Neuroectodermal Tumors Diseases 0.000 claims description 10
• 208000007660 Residual Neoplasm Diseases 0.000 claims description 10
• 210000000988 bone and bone Anatomy 0.000 claims description 10
• 230000036210 malignancy Effects 0.000 claims description 10
• 230000002611 ovarian Effects 0.000 claims description 10
• 230000001105 regulatory effect Effects 0.000 claims description 10
• 206010005949 Bone cancer Diseases 0.000 claims description 9
• 208000018084 Bone neoplasm Diseases 0.000 claims description 9
• 206010008342 Cervix carcinoma Diseases 0.000 claims description 9
• 206010014733 Endometrial cancer Diseases 0.000 claims description 9
• 206010014759 Endometrial neoplasm Diseases 0.000 claims description 9
• 208000006168 Ewing Sarcoma Diseases 0.000 claims description 9
• 208000002250 Hematologic Neoplasms Diseases 0.000 claims description 9
• 208000018142 Leiomyosarcoma Diseases 0.000 claims description 9
• 206010033128 Ovarian cancer Diseases 0.000 claims description 9
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 9
• 208000032383 Soft tissue cancer Diseases 0.000 claims description 9
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 9
• 208000008383 Wilms tumor Diseases 0.000 claims description 9
• 201000010881 cervical cancer Diseases 0.000 claims description 9
• 210000003128 head Anatomy 0.000 claims description 9
• 230000009033 hematopoietic malignancy Effects 0.000 claims description 9
• 208000032839 leukemia Diseases 0.000 claims description 9
• 210000003739 neck Anatomy 0.000 claims description 9
• 201000008026 nephroblastoma Diseases 0.000 claims description 9
• 206010003571 Astrocytoma Diseases 0.000 claims description 8
• 239000013604 expression vector Substances 0.000 claims description 8
• 208000005017 glioblastoma Diseases 0.000 claims description 8
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 7
• 208000028564 B-cell non-Hodgkin lymphoma Diseases 0.000 claims description 6
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 6
• 239000000969 carrier Substances 0.000 claims description 6
• 208000037615 chronic lymphocytic susceptibility to 2 leukemia Diseases 0.000 claims description 6
• 238000009472 formulation Methods 0.000 claims description 6
• 102000050405 human PSCA Human genes 0.000 claims description 6
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 5
• 208000037832 acute lymphoblastic B-cell leukemia Diseases 0.000 claims description 5
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
• 239000003381 stabilizer Substances 0.000 claims description 4
• 101000884275 Homo sapiens Endosialin Proteins 0.000 claims description 3
• 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 claims description 3
• 238000012258 culturing Methods 0.000 claims description 3
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
• 102000014429 Insulin-like growth factor Human genes 0.000 claims 2
• 101000972946 Homo sapiens Hepatocyte growth factor receptor Proteins 0.000 claims 1
• 239000002253 acid Substances 0.000 claims 1
• 102000057421 human MET Human genes 0.000 claims 1
• 210000004027 cell Anatomy 0.000 abstract description 144
• 102100037852 Insulin-like growth factor I Human genes 0.000 abstract description 7
• 239000003102 growth factor Substances 0.000 abstract description 3
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 abstract 1
• 102000038455 IGF Type 1 Receptor Human genes 0.000 abstract 1
• 108010031794 IGF Type 1 Receptor Proteins 0.000 abstract 1
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 257
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 257
• 108090000623 proteins and genes Proteins 0.000 description 73
• 241000282553 Macaca Species 0.000 description 64
• 241001465754 Metazoa Species 0.000 description 52
• 239000012634 fragment Substances 0.000 description 51
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 50
• 235000001014 amino acid Nutrition 0.000 description 48
• 229940024606 amino acid Drugs 0.000 description 47
• 150000001413 amino acids Chemical class 0.000 description 47
• 238000012360 testing method Methods 0.000 description 47
• 230000000694 effects Effects 0.000 description 46
• 102000004169 proteins and genes Human genes 0.000 description 43
• 235000018102 proteins Nutrition 0.000 description 42
• 241000894007 species Species 0.000 description 41
• 241000282412 Homo Species 0.000 description 38
• 241000288906 Primates Species 0.000 description 38
• 210000001744 T-lymphocyte Anatomy 0.000 description 38
• 125000000539 amino acid group Chemical group 0.000 description 38
• 241000282693 Cercopithecidae Species 0.000 description 37
• 238000013459 approach Methods 0.000 description 32
• 230000000875 corresponding effect Effects 0.000 description 32
• 241000288951 Callithrix <genus> Species 0.000 description 30
• 230000001225 therapeutic effect Effects 0.000 description 30
• 101710160107 Outer membrane protein A Proteins 0.000 description 27
• 241000282567 Macaca fascicularis Species 0.000 description 26
• 210000004369 blood Anatomy 0.000 description 22
• 239000008280 blood Substances 0.000 description 22
• 210000001519 tissue Anatomy 0.000 description 22
• 241001515942 marmosets Species 0.000 description 21
• 239000002773 nucleotide Substances 0.000 description 21
• 125000003729 nucleotide group Chemical group 0.000 description 21
• 238000002560 therapeutic procedure Methods 0.000 description 21
• 241000282560 Macaca mulatta Species 0.000 description 20
• 239000002299 complementary DNA Substances 0.000 description 20
• 229940000406 drug candidate Drugs 0.000 description 18
• 238000011156 evaluation Methods 0.000 description 18
• 101001056234 Homo sapiens Sperm mitochondrial-associated cysteine-rich protein Proteins 0.000 description 17
• 230000001747 exhibiting effect Effects 0.000 description 17
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 16
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 16
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 15
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 15
• 241001123862 Mico Species 0.000 description 14
• 102100026503 Sperm mitochondrial-associated cysteine-rich protein Human genes 0.000 description 14
• 230000002411 adverse Effects 0.000 description 14
• 230000006870 function Effects 0.000 description 14
• 101000916489 Homo sapiens Chondroitin sulfate proteoglycan 4 Proteins 0.000 description 13
• 101000829725 Homo sapiens Phospholipid hydroperoxide glutathione peroxidase Proteins 0.000 description 13
• 238000003556 assay Methods 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 239000012071 phase Substances 0.000 description 13
• 241000530410 Trachypithecus Species 0.000 description 12
• 241000282579 Pan Species 0.000 description 11
• 241000283984 Rodentia Species 0.000 description 11
• 230000008901 benefit Effects 0.000 description 11
• 230000001472 cytotoxic effect Effects 0.000 description 11
• 230000012010 growth Effects 0.000 description 11
• 230000035772 mutation Effects 0.000 description 11
• 239000013642 negative control Substances 0.000 description 11
• 229940124597 therapeutic agent Drugs 0.000 description 11
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 10
• 102100038358 Prostate-specific antigen Human genes 0.000 description 10
• 210000002950 fibroblast Anatomy 0.000 description 10
• 230000001404 mediated effect Effects 0.000 description 10
• 238000000746 purification Methods 0.000 description 10
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
• 241001529936 Murinae Species 0.000 description 9
• 241000288935 Platyrrhini Species 0.000 description 9
• 241000282696 Saimiri sciureus Species 0.000 description 9
• 230000004913 activation Effects 0.000 description 9
• 235000004279 alanine Nutrition 0.000 description 9
• 239000011324 bead Substances 0.000 description 9
• 239000012636 effector Substances 0.000 description 9
• 230000003993 interaction Effects 0.000 description 9
• 239000000523 sample Substances 0.000 description 9
• 238000012216 screening Methods 0.000 description 9
• 230000011664 signaling Effects 0.000 description 9
• 230000009870 specific binding Effects 0.000 description 9
• 230000008093 supporting effect Effects 0.000 description 9
• 230000008685 targeting Effects 0.000 description 9
• 241000288950 Callithrix jacchus Species 0.000 description 8
• 108091026890 Coding region Proteins 0.000 description 8
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 8
• 201000004681 Psoriasis Diseases 0.000 description 8
• 230000004071 biological effect Effects 0.000 description 8
• 210000004204 blood vessel Anatomy 0.000 description 8
• 210000004899 c-terminal region Anatomy 0.000 description 8
• 230000001419 dependent effect Effects 0.000 description 8
• 238000001514 detection method Methods 0.000 description 8
• 210000002889 endothelial cell Anatomy 0.000 description 8
• 238000002955 isolation Methods 0.000 description 8
• 239000003446 ligand Substances 0.000 description 8
• 239000007787 solid Substances 0.000 description 8
• 210000004881 tumor cell Anatomy 0.000 description 8
• 101710117290 Aldo-keto reductase family 1 member C4 Proteins 0.000 description 7
• 108020005098 Anticodon Proteins 0.000 description 7
• 241000894006 Bacteria Species 0.000 description 7
• 241000282551 Cercopithecus Species 0.000 description 7
• 108020004705 Codon Proteins 0.000 description 7
• 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 7
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 7
• 241000699670 Mus sp. Species 0.000 description 7
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 7
• 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 7
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 7
• 241000277925 Piliocolobus foai Species 0.000 description 7
• 102100024952 Protein CBFA2T1 Human genes 0.000 description 7
• 241000282695 Saimiri Species 0.000 description 7
• 108020004566 Transfer RNA Proteins 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 7
• 210000000170 cell membrane Anatomy 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 230000000670 limiting effect Effects 0.000 description 7
• 238000002823 phage display Methods 0.000 description 7
• 238000002864 sequence alignment Methods 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 210000000130 stem cell Anatomy 0.000 description 7
• 108060003951 Immunoglobulin Proteins 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 108700020796 Oncogene Proteins 0.000 description 6
• 241001504519 Papio ursinus Species 0.000 description 6
• 241000288961 Saguinus imperator Species 0.000 description 6
• 241000700605 Viruses Species 0.000 description 6
• 238000010521 absorption reaction Methods 0.000 description 6
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 6
• 238000010367 cloning Methods 0.000 description 6
• 230000003013 cytotoxicity Effects 0.000 description 6
• 231100000135 cytotoxicity Toxicity 0.000 description 6
• 230000034994 death Effects 0.000 description 6
• 231100000517 death Toxicity 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 230000018109 developmental process Effects 0.000 description 6
• 102000037865 fusion proteins Human genes 0.000 description 6
• 108020001507 fusion proteins Proteins 0.000 description 6
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 6
• 239000000833 heterodimer Substances 0.000 description 6
• 238000009396 hybridization Methods 0.000 description 6
• 210000004408 hybridoma Anatomy 0.000 description 6
• 102000018358 immunoglobulin Human genes 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 230000002018 overexpression Effects 0.000 description 6
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 6
• 210000002966 serum Anatomy 0.000 description 6
• 238000010561 standard procedure Methods 0.000 description 6
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical compound OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
• 241000282691 Cercocebus Species 0.000 description 5
• 241001504544 Cercopithecus mona Species 0.000 description 5
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
• 241000196324 Embryophyta Species 0.000 description 5
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 5
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 5
• 239000004471 Glycine Substances 0.000 description 5
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 5
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 5
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
• 241000282559 Macaca sylvanus Species 0.000 description 5
• 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 5
• 108091000080 Phosphotransferase Proteins 0.000 description 5
• 241000367425 Piliocolobus badius Species 0.000 description 5
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 5
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 5
• 241000288959 Saguinus Species 0.000 description 5
• 241000288960 Saguinus oedipus Species 0.000 description 5
• 241000015710 Semnopithecus Species 0.000 description 5
• 231100000504 carcinogenesis Toxicity 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 239000012530 fluid Substances 0.000 description 5
• 210000004602 germ cell Anatomy 0.000 description 5
• 229930195712 glutamate Natural products 0.000 description 5
• 229940049906 glutamate Drugs 0.000 description 5
• 210000005260 human cell Anatomy 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 230000000977 initiatory effect Effects 0.000 description 5
• RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 5
• 230000002147 killing effect Effects 0.000 description 5
• 230000003211 malignant effect Effects 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 238000010369 molecular cloning Methods 0.000 description 5
• 210000004898 n-terminal fragment Anatomy 0.000 description 5
• 102000020233 phosphotransferase Human genes 0.000 description 5
• 230000003389 potentiating effect Effects 0.000 description 5
• 230000002829 reductive effect Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 210000002536 stromal cell Anatomy 0.000 description 5
• 238000006467 substitution reaction Methods 0.000 description 5
• 230000009261 transgenic effect Effects 0.000 description 5
• 235000002374 tyrosine Nutrition 0.000 description 5
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
• 208000005623 Carcinogenesis Diseases 0.000 description 4
• 208000024172 Cardiovascular disease Diseases 0.000 description 4
• 241000282533 Colobinae Species 0.000 description 4
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 4
• 108090001061 Insulin Proteins 0.000 description 4
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
• 241001277090 Lophocebus Species 0.000 description 4
• 241001277092 Lophocebus albigena Species 0.000 description 4
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 4
• 241000282566 Macaca arctoides Species 0.000 description 4
• 241000282564 Macaca fuscata Species 0.000 description 4
• 241000293886 Macaca maura Species 0.000 description 4
• 241000282561 Macaca nemestrina Species 0.000 description 4
• 241000282562 Macaca radiata Species 0.000 description 4
• 241000282522 Macaca sinica Species 0.000 description 4
• 241000282516 Papio anubis Species 0.000 description 4
• 241000282517 Papio cynocephalus Species 0.000 description 4
• 241000282604 Presbytis Species 0.000 description 4
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 4
• 241000282898 Sus scrofa Species 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 238000012867 alanine scanning Methods 0.000 description 4
• 230000000890 antigenic effect Effects 0.000 description 4
• 230000006907 apoptotic process Effects 0.000 description 4
• 235000009582 asparagine Nutrition 0.000 description 4
• 229960001230 asparagine Drugs 0.000 description 4
• CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
• MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 4
• 239000011230 binding agent Substances 0.000 description 4
• 230000036952 cancer formation Effects 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 238000011262 co‐therapy Methods 0.000 description 4
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
• 230000008030 elimination Effects 0.000 description 4
• 238000003379 elimination reaction Methods 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 230000003511 endothelial effect Effects 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 210000003527 eukaryotic cell Anatomy 0.000 description 4
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
• 235000014304 histidine Nutrition 0.000 description 4
• 102000049443 human SMCP Human genes 0.000 description 4
• 230000003834 intracellular effect Effects 0.000 description 4
• 238000012423 maintenance Methods 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 230000001575 pathological effect Effects 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• 102000040430 polynucleotide Human genes 0.000 description 4
• 108091033319 polynucleotide Proteins 0.000 description 4
• 239000002157 polynucleotide Substances 0.000 description 4
• 238000010188 recombinant method Methods 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 239000007790 solid phase Substances 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 238000007920 subcutaneous administration Methods 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 230000004614 tumor growth Effects 0.000 description 4
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 241000282556 Cercocebus atys Species 0.000 description 3
• 241000282690 Cercopithecinae Species 0.000 description 3
• 241000282602 Colobus Species 0.000 description 3
• 108020004414 DNA Proteins 0.000 description 3
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 3
• 101150084967 EPCAM gene Proteins 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 3
• 102000004877 Insulin Human genes 0.000 description 3
• 108010001127 Insulin Receptor Proteins 0.000 description 3
• 102100036721 Insulin receptor Human genes 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 241000282521 Macaca assamensis Species 0.000 description 3
• 241000532835 Macaca nigra Species 0.000 description 3
• 241000293895 Macaca ochreata Species 0.000 description 3
• 241000124843 Macaca tonkeana Species 0.000 description 3
• 206010027476 Metastases Diseases 0.000 description 3
• 241000282515 Papio hamadryas Species 0.000 description 3
• 241001443706 Papio papio Species 0.000 description 3
• 241000277951 Piliocolobus pennantii Species 0.000 description 3
• 239000004698 Polyethylene Substances 0.000 description 3
• 101710182846 Polyhedrin Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• 229920002684 Sepharose Polymers 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 102000013275 Somatomedins Human genes 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 241000533339 Trachypithecus cristatus Species 0.000 description 3
• 241000530356 Trachypithecus obscurus Species 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 239000013543 active substance Substances 0.000 description 3
• 230000033115 angiogenesis Effects 0.000 description 3
• 229940009098 aspartate Drugs 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 230000010261 cell growth Effects 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
• 238000003745 diagnosis Methods 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 3
• 210000003038 endothelium Anatomy 0.000 description 3
• 210000002919 epithelial cell Anatomy 0.000 description 3
• 238000000605 extraction Methods 0.000 description 3
• 230000002349 favourable effect Effects 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 238000001415 gene therapy Methods 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• 229960000310 isoleucine Drugs 0.000 description 3
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 208000029340 primitive neuroectodermal tumor Diseases 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 230000004224 protection Effects 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000007115 recruitment Effects 0.000 description 3
• 238000009781 safety test method Methods 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 230000006641 stabilisation Effects 0.000 description 3
• 238000011105 stabilization Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 231100000041 toxicology testing Toxicity 0.000 description 3
• 102000035160 transmembrane proteins Human genes 0.000 description 3
• 108091005703 transmembrane proteins Proteins 0.000 description 3
• 238000011269 treatment regimen Methods 0.000 description 3
• 150000003668 tyrosines Chemical class 0.000 description 3
• 241000530406 Allenopithecus nigroviridis Species 0.000 description 2
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
• 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
• 102000004506 Blood Proteins Human genes 0.000 description 2
• 108010017384 Blood Proteins Proteins 0.000 description 2
• 241000288952 Callithrix argentata Species 0.000 description 2
• 101710132601 Capsid protein Proteins 0.000 description 2
• 241001376293 Cercocebus agilis Species 0.000 description 2
• 241000282557 Cercocebus galeritus Species 0.000 description 2
• 241001272559 Cercopithecoidea Species 0.000 description 2
• 241000282549 Cercopithecus cephus Species 0.000 description 2
• 241000720696 Cercopithecus denti Species 0.000 description 2
• 241001504539 Cercopithecus diana Species 0.000 description 2
• 241000718135 Cercopithecus doggetti Species 0.000 description 2
• 241000717100 Cercopithecus dryas Species 0.000 description 2
• 241000337059 Cercopithecus erythrogaster Species 0.000 description 2
• 241000413410 Cercopithecus erythrotis Species 0.000 description 2
• 241000282550 Cercopithecus hamlyni Species 0.000 description 2
• 241000717099 Cercopithecus roloway Species 0.000 description 2
• 241001058750 Cercopithecus sclateri Species 0.000 description 2
• 241000862448 Chlorocebus Species 0.000 description 2
• 241001097145 Chlorocebus cynosuros Species 0.000 description 2
• 241000867610 Chlorocebus pygerythrus Species 0.000 description 2
• 241000530382 Colobus angolensis Species 0.000 description 2
• 241001466851 Colobus guereza Species 0.000 description 2
• 241000282601 Colobus polykomos Species 0.000 description 2
• 241000730883 Colobus satanas Species 0.000 description 2
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 229920002307 Dextran Polymers 0.000 description 2
• 238000012286 ELISA Assay Methods 0.000 description 2
• 241000282555 Erythrocebus patas Species 0.000 description 2
• 108091006020 Fc-tagged proteins Proteins 0.000 description 2
• 102000013382 Gelatinases Human genes 0.000 description 2
• 108010026132 Gelatinases Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 101100383038 Homo sapiens CD19 gene Proteins 0.000 description 2
• 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 description 2
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 102100025087 Insulin receptor substrate 1 Human genes 0.000 description 2
• 101710201824 Insulin receptor substrate 1 Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• 241000293888 Macaca hecki Species 0.000 description 2
• 241000601290 Macaca munzala Species 0.000 description 2
• 241001013900 Macaca siberu Species 0.000 description 2
• 241000532828 Macaca silenus Species 0.000 description 2
• 241000532830 Macaca thibetana Species 0.000 description 2
• 241000282537 Mandrillus sphinx Species 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 102100026712 Metalloreductase STEAP1 Human genes 0.000 description 2
• 241001448472 Miopithecus ogouensis Species 0.000 description 2
• 241001504668 Miopithecus talapoin Species 0.000 description 2
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
• 241000158526 Nasalis Species 0.000 description 2
• 206010029113 Neovascularisation Diseases 0.000 description 2
• AHLPHDHHMVZTML-UHFFFAOYSA-N Ornithine Chemical compound NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
• 102100021079 Ornithine decarboxylase Human genes 0.000 description 2
• 108700005126 Ornithine decarboxylases Proteins 0.000 description 2
• 241000282520 Papio Species 0.000 description 2
• 241000277924 Piliocolobus kirkii Species 0.000 description 2
• 241000277952 Piliocolobus preussi Species 0.000 description 2
• 241000277920 Piliocolobus tephrosceles Species 0.000 description 2
• 241000276498 Pollachius virens Species 0.000 description 2
• 241000206607 Porphyra umbilicalis Species 0.000 description 2
• 241001372382 Presbytis chrysomelas Species 0.000 description 2
• 241001372378 Presbytis hosei Species 0.000 description 2
• 241001372154 Presbytis thomasi Species 0.000 description 2
• 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
• 241000881858 Rhinopithecus bieti Species 0.000 description 2
• 241000276459 Rhinopithecus brelichi Species 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
• 241000027720 Semnopithecus hector Species 0.000 description 2
• 241001016068 Semnopithecus hypoleucos Species 0.000 description 2
• 241001016066 Semnopithecus priam Species 0.000 description 2
• 241000966334 Simias Species 0.000 description 2
• 241000680159 Simias concolor Species 0.000 description 2
• 108020004459 Small interfering RNA Proteins 0.000 description 2
• 241000256251 Spodoptera frugiperda Species 0.000 description 2
• 241000168914 Strepsirrhini Species 0.000 description 2
• 230000005867 T cell response Effects 0.000 description 2
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 2
• 101150052863 THY1 gene Proteins 0.000 description 2
• 241000288940 Tarsius Species 0.000 description 2
• 241000282539 Theropithecus gelada Species 0.000 description 2
• 241001154123 Trachypithecus delacouri Species 0.000 description 2
• 241000409963 Trachypithecus germaini Species 0.000 description 2
• 241000027718 Trachypithecus hatinhensis Species 0.000 description 2
• 241001154124 Trachypithecus laotum Species 0.000 description 2
• 241001154119 Trachypithecus poliocephalus Species 0.000 description 2
• 241001311562 Trachypithecus shortridgei Species 0.000 description 2
• 241000530413 Trachypithecus vetulus Species 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 229940127174 UCHT1 Drugs 0.000 description 2
• 206010046543 Urinary incontinence Diseases 0.000 description 2
• 229930003427 Vitamin E Natural products 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 230000001772 anti-angiogenic effect Effects 0.000 description 2
• 230000006909 anti-apoptosis Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 2
• 229960003008 blinatumomab Drugs 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 238000004820 blood count Methods 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 238000009583 bone marrow aspiration Methods 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 230000004709 cell invasion Effects 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 230000015271 coagulation Effects 0.000 description 2
• 238000005345 coagulation Methods 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 230000006552 constitutive activation Effects 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 210000005220 cytoplasmic tail Anatomy 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 210000001723 extracellular space Anatomy 0.000 description 2
• 238000010579 first pass effect Methods 0.000 description 2
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• 230000007614 genetic variation Effects 0.000 description 2
• 208000019622 heart disease Diseases 0.000 description 2
• 230000002440 hepatic effect Effects 0.000 description 2
• 238000005734 heterodimerization reaction Methods 0.000 description 2
• 239000000710 homodimer Substances 0.000 description 2
• 230000006303 immediate early viral mRNA transcription Effects 0.000 description 2
• 239000012642 immune effector Substances 0.000 description 2
• 230000008105 immune reaction Effects 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 229940121354 immunomodulator Drugs 0.000 description 2
• 239000003018 immunosuppressive agent Substances 0.000 description 2
• 238000009169 immunotherapy Methods 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000001965 increasing effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 230000009401 metastasis Effects 0.000 description 2
• 239000003226 mitogen Substances 0.000 description 2
• 230000002297 mitogenic effect Effects 0.000 description 2
• 238000003032 molecular docking Methods 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 238000006384 oligomerization reaction Methods 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 239000002953 phosphate buffered saline Substances 0.000 description 2
• 229920000570 polyether Polymers 0.000 description 2
• 229920000136 polysorbate Polymers 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 208000023958 prostate neoplasm Diseases 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 239000011435 rock Substances 0.000 description 2
• 229910052711 selenium Inorganic materials 0.000 description 2
• 239000011669 selenium Substances 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
• 239000004055 small Interfering RNA Substances 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 235000002639 sodium chloride Nutrition 0.000 description 2
• 230000000392 somatic effect Effects 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 229940126585 therapeutic drug Drugs 0.000 description 2
• 238000003325 tomography Methods 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 230000005747 tumor angiogenesis Effects 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 235000019165 vitamin E Nutrition 0.000 description 2
• 239000011709 vitamin E Substances 0.000 description 2
• 229940046009 vitamin E Drugs 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• HDTRYLNUVZCQOY-UHFFFAOYSA-N &alpha;-D-glucopyranosyl-&alpha;-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
• CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
• HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical group NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• ORJCWNHUOREFAT-UHFFFAOYSA-N 7,8-dimethylquinoxalino[2,3-f][1,10]phenanthroline Chemical compound C1=CC=C2N=C(C=3C(=NC=C(C=3C)C)C=3C4=CC=CN=3)C4=NC2=C1 ORJCWNHUOREFAT-UHFFFAOYSA-N 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000007788 Acute Liver Failure Diseases 0.000 description 1
• 206010000804 Acute hepatic failure Diseases 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 241001326056 Allochrocebus solatus Species 0.000 description 1
• 208000000044 Amnesia Diseases 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 241001465318 Aspergillus terreus Species 0.000 description 1
• 241001422755 Atys Species 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 101710117995 B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 108090000342 C-Type Lectins Proteins 0.000 description 1
• 102000003930 C-Type Lectins Human genes 0.000 description 1
• 102000002086 C-type lectin-like Human genes 0.000 description 1
• 108050009406 C-type lectin-like Proteins 0.000 description 1
• 241001396247 Callithrix chrysoleuca Species 0.000 description 1
• 241000482856 Callithrix flaviceps Species 0.000 description 1
• 241000509531 Callithrix humeralifera Species 0.000 description 1
• 241000601458 Callithrix humilis Species 0.000 description 1
• 241000027635 Callithrix kuhlii Species 0.000 description 1
• 241000282512 Callithrix pygmaea Species 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000282692 Catarrhini Species 0.000 description 1
• 241000282513 Cebidae Species 0.000 description 1
• 241001123863 Cebuella Species 0.000 description 1
• 241000282558 Cercocebus torquatus Species 0.000 description 1
• 241000027672 Cercopithecus albogularis Species 0.000 description 1
• 241001504542 Cercopithecus ascanius Species 0.000 description 1
• 241000718131 Cercopithecus kandti Species 0.000 description 1
• 241001504514 Cercopithecus neglectus Species 0.000 description 1
• 241001504511 Cercopithecus nictitans Species 0.000 description 1
• 241001448473 Cercopithecus petaurista Species 0.000 description 1
• 241001464958 Cercopithecus pogonias Species 0.000 description 1
• 241000065660 Cercopithecus wolfi Species 0.000 description 1
• 241000168917 Chiromyiformes Species 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 241000558296 Chlorocebus djamdjamensis Species 0.000 description 1
• 241000867607 Chlorocebus sabaeus Species 0.000 description 1
• 241000867618 Chlorocebus tantalus Species 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 101710094648 Coat protein Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 241001481822 Colobus sp. Species 0.000 description 1
• 241000198208 Colobus vellerosus Species 0.000 description 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
• 206010010301 Confusion and disorientation Diseases 0.000 description 1
• 241001417483 Cryptacanthodidae Species 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 241001416561 Daubentoniidae Species 0.000 description 1
• 206010011968 Decreased immune responsiveness Diseases 0.000 description 1
• 102100036966 Dipeptidyl aminopeptidase-like protein 6 Human genes 0.000 description 1
• 101710092625 Dipeptidyl aminopeptidase-like protein 6 Proteins 0.000 description 1
• 241000758827 Ebenus Species 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 235000002139 Emilia sonchifolia Nutrition 0.000 description 1
• 240000000279 Emilia sonchifolia Species 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 102100031940 Epithelial cell adhesion molecule Human genes 0.000 description 1
• 241000282554 Erythrocebus Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000289695 Eutheria Species 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 241000724791 Filamentous phage Species 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• 102100035233 Furin Human genes 0.000 description 1
• 108090001126 Furin Proteins 0.000 description 1
• 241000122126 Galagidae Species 0.000 description 1
• 239000001828 Gelatine Substances 0.000 description 1
• QMOSCLNJVKSHHU-YUMQZZPRSA-N Glu-Met-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O QMOSCLNJVKSHHU-YUMQZZPRSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 241001554831 Hamadryas <angiosperm> Species 0.000 description 1
• 241000168913 Haplorrhini Species 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101500024917 Homo sapiens Tumor necrosis factor, membrane form Proteins 0.000 description 1
• 241000282620 Hylobates sp. Species 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 101150088952 IGF1 gene Proteins 0.000 description 1
• 101150002416 Igf2 gene Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
• 102100025092 Insulin receptor substrate 2 Human genes 0.000 description 1
• 101710201820 Insulin receptor substrate 2 Proteins 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 101710180643 Leishmanolysin Proteins 0.000 description 1
• 241000288904 Lemur Species 0.000 description 1
• 241000288903 Lemuridae Species 0.000 description 1
• 241000168911 Lemuriformes Species 0.000 description 1
• 241000034246 Leucophaeus Species 0.000 description 1
• 241001277091 Lophocebus albigena albigena Species 0.000 description 1
• 241001277089 Lophocebus aterrimus Species 0.000 description 1
• 241000288986 Lorisidae Species 0.000 description 1
• 241000168918 Lorisiformes Species 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
• 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
• JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 101150105382 MET gene Proteins 0.000 description 1
• 241000293893 Macaca leonina Species 0.000 description 1
• 241000583489 Macaca pagensis Species 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 241000282534 Mandrillus Species 0.000 description 1
• 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 206010027452 Metastases to bone Diseases 0.000 description 1
• 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
• 241001504671 Miopithecus Species 0.000 description 1
• 208000034486 Multi-organ failure Diseases 0.000 description 1
• 208000010718 Multiple Organ Failure Diseases 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101100365690 Mus musculus Shc1 gene Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 241000158423 Nasalis larvatus Species 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 108010000240 O-sialoglycoprotein endopeptidase Proteins 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 241000282576 Pan paniscus Species 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 101150034459 Parpbp gene Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
• 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
• 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
• 241000550811 Piliocolobus badius badius Species 0.000 description 1
• 241000550813 Piliocolobus badius temminckii Species 0.000 description 1
• 241000277921 Piliocolobus gordonorum Species 0.000 description 1
• 241000277922 Piliocolobus rufomitratus Species 0.000 description 1
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
• 229920002560 Polyethylene Glycol 3000 Polymers 0.000 description 1
• 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
• 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 239000004721 Polyphenylene oxide Substances 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 229920001214 Polysorbate 60 Polymers 0.000 description 1
• 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 241001372377 Presbytis frontata Species 0.000 description 1
• 241001312916 Presbytis melalophos Species 0.000 description 1
• 241001372369 Presbytis potenziani Species 0.000 description 1
• 241001372152 Presbytis rubicunda Species 0.000 description 1
• 101710083689 Probable capsid protein Proteins 0.000 description 1
• 102100037775 Probable tRNA N6-adenosine threonylcarbamoyltransferase Human genes 0.000 description 1
• 241000367426 Procolobus Species 0.000 description 1
• 241000130363 Procolobus verus Species 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 241000530385 Pygathrix Species 0.000 description 1
• 241000005091 Pygathrix cinerea Species 0.000 description 1
• 241000530389 Pygathrix nemaeus Species 0.000 description 1
• 241001221333 Pygathrix nigripes Species 0.000 description 1
• 108091005682 Receptor kinases Proteins 0.000 description 1
• 241000118407 Rhinopithecus Species 0.000 description 1
• 241000931180 Rhinopithecus avunculus Species 0.000 description 1
• 241000881856 Rhinopithecus roxellana Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000118349 Rungwecebus kipunji Species 0.000 description 1
• 241000815718 Saguinus inustus Species 0.000 description 1
• 241001416140 Saguinus midas Species 0.000 description 1
• 241000288956 Saguinus mystax Species 0.000 description 1
• 241001125016 Saimiri boliviensis Species 0.000 description 1
• 241001223354 Saimiri oerstedii Species 0.000 description 1
• 241000932818 Saimiri ustus Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 241000160761 Satyrus Species 0.000 description 1
• 102000009203 Sema domains Human genes 0.000 description 1
• 108050000099 Sema domains Proteins 0.000 description 1
• 108050003978 Semaphorin Proteins 0.000 description 1
• 102000014105 Semaphorin Human genes 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 241000607715 Serratia marcescens Species 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 241001272562 Simiiformes Species 0.000 description 1
• 240000003768 Solanum lycopersicum Species 0.000 description 1
• 240000006394 Sorghum bicolor Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 241000288942 Tarsiidae Species 0.000 description 1
• 241000168912 Tarsiiformes Species 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 241000282538 Theropithecus Species 0.000 description 1
• 102100026966 Thrombomodulin Human genes 0.000 description 1
• 108010079274 Thrombomodulin Proteins 0.000 description 1
• 241000256648 Trachypithecus auratus Species 0.000 description 1
• 241000530355 Trachypithecus francoisi Species 0.000 description 1
• 241000367442 Trachypithecus geei Species 0.000 description 1
• 241000367439 Trachypithecus pileatus Species 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
• 241000255985 Trichoplusia Species 0.000 description 1
• 241001504501 Troglodytes Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
• 241000208041 Veronica Species 0.000 description 1
• 208000012886 Vertigo Diseases 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 231100000836 acute liver failure Toxicity 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 239000012082 adaptor molecule Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 230000008860 allosteric change Effects 0.000 description 1
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
• 102000006707 alpha-beta T-Cell Antigen Receptors Human genes 0.000 description 1
• 108010087408 alpha-beta T-Cell Antigen Receptors Proteins 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 201000007201 aphasia Diseases 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229960003121 arginine Drugs 0.000 description 1
• 206010003119 arrhythmia Diseases 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 101150006362 atl gene Proteins 0.000 description 1
• 230000003305 autocrine Effects 0.000 description 1
• 210000000270 basal cell Anatomy 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 239000000090 biomarker Substances 0.000 description 1
• CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
• 230000000711 cancerogenic effect Effects 0.000 description 1
• FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
• 229960003669 carbenicillin Drugs 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 108020001778 catalytic domains Proteins 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 230000005859 cell recognition Effects 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 238000013375 chromatographic separation Methods 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 238000002591 computed tomography Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 208000004209 confusion Diseases 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 210000004246 corpus luteum Anatomy 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 238000007822 cytometric assay Methods 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000002354 daily effect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000000593 degrading effect Effects 0.000 description 1
• 230000002074 deregulated effect Effects 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 208000002173 dizziness Diseases 0.000 description 1
• 231100000371 dose-limiting toxicity Toxicity 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 108091007231 endothelial receptors Proteins 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 230000009841 epithelial lesion Effects 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
• 229960004039 finasteride Drugs 0.000 description 1
• 210000000285 follicular dendritic cell Anatomy 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 description 1
• 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 description 1
• 210000005095 gastrointestinal system Anatomy 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 230000004077 genetic alteration Effects 0.000 description 1
• 231100000118 genetic alteration Toxicity 0.000 description 1
• 238000012268 genome sequencing Methods 0.000 description 1
• 210000002980 germ line cell Anatomy 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 235000009569 green tea Nutrition 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 208000013210 hematogenous Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 210000000777 hematopoietic system Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 101150113423 hisD gene Proteins 0.000 description 1
• 230000001744 histochemical effect Effects 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 210000000428 immunological synapse Anatomy 0.000 description 1
• 230000036046 immunoreaction Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 210000003093 intracellular space Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 231100000863 loss of memory Toxicity 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 235000012661 lycopene Nutrition 0.000 description 1
• 239000001751 lycopene Substances 0.000 description 1
• 229960004999 lycopene Drugs 0.000 description 1
• OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 230000000998 lymphohematopoietic effect Effects 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 229960003646 lysine Drugs 0.000 description 1
• 229960005357 lysine acetate Drugs 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 210000003519 mature b lymphocyte Anatomy 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 208000037819 metastatic cancer Diseases 0.000 description 1
• 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000004412 neuroendocrine cell Anatomy 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 238000011580 nude mouse model Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 230000005959 oncogenic signaling Effects 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 102000027450 oncoproteins Human genes 0.000 description 1
• 108091008819 oncoproteins Proteins 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
• 238000004091 panning Methods 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000013081 phylogenetic analysis Methods 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000193 polymethacrylate Polymers 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 238000002600 positron emission tomography Methods 0.000 description 1
• 231100000683 possible toxicity Toxicity 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 210000001948 pro-b lymphocyte Anatomy 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 210000005267 prostate cell Anatomy 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 210000004777 protein coat Anatomy 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
• 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 238000002702 ribosome display Methods 0.000 description 1
• 231100000279 safety data Toxicity 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000002955 secretory cell Anatomy 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 239000003001 serine protease inhibitor Substances 0.000 description 1
• 101150012554 shc gene Proteins 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 102000009076 src-Family Kinases Human genes 0.000 description 1
• 108010087686 src-Family Kinases Proteins 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 231100000378 teratogenic Toxicity 0.000 description 1
• 230000003390 teratogenic effect Effects 0.000 description 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000013169 thromboelastometry Methods 0.000 description 1
• 230000036962 time dependent Effects 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000027 toxicology Toxicity 0.000 description 1
• ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 206010044412 transitional cell carcinoma Diseases 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 238000004627 transmission electron microscopy Methods 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 210000002993 trophoblast Anatomy 0.000 description 1
• 101150081616 trpB gene Proteins 0.000 description 1
• 101150111232 trpB-1 gene Proteins 0.000 description 1
• 230000000381 tumorigenic effect Effects 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 238000005353 urine analysis Methods 0.000 description 1
• 210000003741 urothelium Anatomy 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 231100000889 vertigo Toxicity 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000000811 xylitol Substances 0.000 description 1
• 235000010447 xylitol Nutrition 0.000 description 1
• HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
• 229960002675 xylitol Drugs 0.000 description 1